NIH Director Francis S. Collins, M.D., Ph.D., today announced the approval of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009.
"I am happy to say that we now have human embryonic stem cell lines eligible for use by our research community under our new stem cell policy," Dr. Collins said. "In accordance with the guidelines, these stem cell lines were derived from embryos that were donated under ethically sound informed consent processes.
PPD, Inc. (Nasdaq: PPDI) today announced it has launched a new global information technology infrastructure for analysis and reporting of clinical trial data. The biostatistics technology infrastructure (BTI) is a centralized computing platform that enhances the company's ability to deliver secure, quality reporting and data analysis to meet client timelines.The virtual server environment allows PPD to deploy global teams of biostatisticians and programmers to projects on a single platform.
The analysis processing environments are located in the same data centers as PPD's
The Boston Consulting Group has provided the new report “Medical Biotechnology in Germany 2009 – Economic Data for Biopharmaceuticals and Therapeutic Progress through Antibodies” for vfa bio.
This yearly report is the only one recording all activities within medical biotechnology in Germany – ranging from startup to big companies.
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture.
